Big Pharma’s Big Lie: The Truth About Innovation & Drug Prices
Can we constrain drug corporations’ unfettered pricing power in the United States and still get the innovation we seek?
Can we constrain drug corporations’ unfettered pricing power in the United States and still get the innovation we seek?
35 pharmaceutical corporations waited until scrutiny on the initial 2021 price hikes faded before hiking prices.
P4AD analyzed the wholesale acquisition cost (WAC) data for the 1,895 unique National Drug Codes (NDCs) with price hikes greater than 1% that were posted between January 1, 2021 and January 6, 2021.
Big Pharma hiked the prices of 636 drugs in the first week of January.
Vital Drugs Important To COVID-Related Outcomes See Big Bumps.
Right now I am on a four-drug combination that carries a list price tag of more than $900,000 per year.
The first case of COVID-19 in the United States was reported on January 20. According to our analysis, pharmaceutical corporations hiked the prices of 245 drugs between January 20 and June 20.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.